{"product_id":"pre-platelet-rich-exosome","title":"PRE Platelet-Rich Exosome | Personalized Assessment","description":"\u003cdiv class=\"geo-editorial-content pre-page-v2\"\u003e\n  \u003cp\u003e\u003cstrong\u003eBeginning with your own blood, treatment planning can be tailored more closely to your individual condition.\u003c\/strong\u003e\u003c\/p\u003e\n  \u003cp\u003ePRE (Platelet-Rich Exosome) is sourced from platelets in the patient’s own blood. After collection, the sample is sent through a specialized preparation, testing, storage, and delivery process. A physician then reviews your medical history, skin or scalp condition, goals, and product documents before planning how PRE may be used.\u003c\/p\u003e\n  \u003cp\u003ePRE is not a ready-made ingredient package, and a concentration or particle count alone cannot predict an outcome. At Geo Aesthetic Clinic, we focus on whether the source is clear, the report is interpreted correctly, and PRE has an appropriate role in your overall care plan.\u003c\/p\u003e\n  \u003cp\u003e\u003cstrong\u003eConsultations are available at all locations:\u003c\/strong\u003e Taipei, Hsinchu, Chiayi, Kaohsiung, and Kinmen. Blood collection and treatment dates depend on the physician’s assessment, clinic schedule, and preparation timeline. \u003ca href=\"\/en\/pages\/location-operating-hours\"\u003eView clinic locations, hours, and booking information\u003c\/a\u003e.\u003c\/p\u003e\n\n  \u003ch2\u003eWhat is PRE?\u003c\/h2\u003e\n  \u003cp\u003ePRE is an autologous platelet-derived exosome material prepared from platelets in the patient’s own blood. Following a professional preparation and testing process, a physician evaluates how it may be used according to the patient’s medical history, health considerations, and treatment goals.\u003c\/p\u003e\n  \u003cp\u003ePRE is not completed immediately after blood collection at the clinic. Preparation, testing, storage, and delivery are required. The actual timeline, number of prepared units, and clinical arrangement must follow the medical assessment and formal preparation documents for that case.\u003c\/p\u003e\n\n  \u003ch2\u003ePRE is more than a vial\u003c\/h2\u003e\n  \u003cp\u003eIt is easy to focus on particle counts or growth-factor names. In medical planning, however, these are only part of the information that needs to be considered.\u003c\/p\u003e\n  \u003cdiv style=\"display:grid;grid-template-columns:repeat(auto-fit,minmax(210px,1fr));gap:16px;margin:24px 0\"\u003e\n    \u003cdiv style=\"padding:20px;border:1px solid #d9e1dc;border-radius:14px\"\u003e\u003ch3 style=\"margin-top:0\"\u003eAutologous source\u003c\/h3\u003e\u003cp\u003ePRE begins with the patient’s own blood. An autologous source does not mean it is appropriate for everyone, so blood-collection conditions, medical history, and medication still need review.\u003c\/p\u003e\u003c\/div\u003e\n    \u003cdiv style=\"padding:20px;border:1px solid #d9e1dc;border-radius:14px\"\u003e\u003ch3 style=\"margin-top:0\"\u003eSpecialized preparation\u003c\/h3\u003e\u003cp\u003eThe collected sample is sent through a specialized preparation process rather than being completed immediately in the consultation room.\u003c\/p\u003e\u003c\/div\u003e\n    \u003cdiv style=\"padding:20px;border:1px solid #d9e1dc;border-radius:14px\"\u003e\u003ch3 style=\"margin-top:0\"\u003eDocument interpretation\u003c\/h3\u003e\u003cp\u003eTest information helps explain the prepared material, but a single value cannot be converted directly into a visible result.\u003c\/p\u003e\u003c\/div\u003e\n    \u003cdiv style=\"padding:20px;border:1px solid #d9e1dc;border-radius:14px\"\u003e\u003ch3 style=\"margin-top:0\"\u003eIndividual planning\u003c\/h3\u003e\u003cp\u003eTreatment area, method, number of sessions, intervals, and combinations with other care are planned by a physician.\u003c\/p\u003e\u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003ch2\u003eHow are PRE and PRP different?\u003c\/h2\u003e\n  \u003cp\u003eBoth may begin with the patient’s own blood, but their final form, preparation location, waiting time, storage requirements, and clinical arrangements differ. The relevant question is not which one is “more advanced,” but which process better fits the treatment goal, health considerations, and acceptable schedule.\u003c\/p\u003e\n  \u003cdiv style=\"overflow-x:auto\"\u003e\u003ctable style=\"width:100%;border-collapse:collapse;min-width:620px\"\u003e\u003cthead\u003e\u003ctr\u003e\u003cth style=\"text-align:left;padding:12px;border-bottom:1px solid #cfd9d2\"\u003eComparison\u003c\/th\u003e\u003cth style=\"text-align:left;padding:12px;border-bottom:1px solid #cfd9d2\"\u003ePRE\u003c\/th\u003e\u003cth style=\"text-align:left;padding:12px;border-bottom:1px solid #cfd9d2\"\u003ePRP\u003c\/th\u003e\u003c\/tr\u003e\u003c\/thead\u003e\u003ctbody\u003e\n    \u003ctr\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eSource\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003ePlatelets from the patient’s own blood\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eThe patient’s own blood\u003c\/td\u003e\u003c\/tr\u003e\n    \u003ctr\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eFinal form\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eProfessionally prepared platelet-derived exosome material\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003ePlatelet-rich plasma prepared by centrifugation\u003c\/td\u003e\u003c\/tr\u003e\n    \u003ctr\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003ePreparation\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eSpecialized preparation, testing, and storage management\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eBlood collection and centrifugation are generally completed at a medical clinic\u003c\/td\u003e\u003c\/tr\u003e\n    \u003ctr\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eTiming\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003ePreparation and testing time is required\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eArranged according to the clinic’s blood-collection process\u003c\/td\u003e\u003c\/tr\u003e\n    \u003ctr\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003ePlanning\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eMedical history, goals, product documents, and physician assessment\u003c\/td\u003e\u003ctd style=\"padding:12px;border-bottom:1px solid #edf0ee\"\u003eCurrent blood sample, goals, and physician assessment\u003c\/td\u003e\u003c\/tr\u003e\n  \u003c\/tbody\u003e\u003c\/table\u003e\u003c\/div\u003e\n  \u003cp\u003e\u003csmall\u003ePRE and PRP should not be ranked as a simple higher- or lower-tier choice, and suitability cannot be determined by concentration, particle count, or a single test result alone.\u003c\/small\u003e\u003c\/p\u003e\n\n  \u003ch2\u003eHow should growth-factor information be read?\u003c\/h2\u003e\n  \u003cp\u003eBIONET materials mention PDGF, IGF-1, and Angiogenin. These names may help patients understand the product documents, but they cannot by themselves predict an individual clinical response.\u003c\/p\u003e\n  \u003ch3\u003ePDGF | Platelet-derived growth factor\u003c\/h3\u003e\n  \u003cp\u003ePDGF is one of the growth factors studied in cell signaling and tissue repair. If it appears in the product documents, a physician interprets it together with the treatment goal and individual condition rather than treating the value as a guarantee.\u003c\/p\u003e\n  \u003ch3\u003eIGF-1 | Insulin-like growth factor 1\u003c\/h3\u003e\n  \u003cp\u003eIGF-1 is associated with cellular growth, metabolism, and tissue responses. A report value alone cannot indicate how much the skin or scalp will change; diagnosis, treatment method, and follow-up remain essential.\u003c\/p\u003e\n  \u003ch3\u003eAngiogenin\u003c\/h3\u003e\n  \u003cp\u003eAngiogenin is a protein studied in relation to angiogenesis and cellular signaling. Its meaning in a prepared product should be explained from the formal report and should not be converted into a promise of individual results.\u003c\/p\u003e\n  \u003cp\u003e\u003csmall\u003eA test report provides additional information for the medical team. It is not a scorecard or a guarantee of outcome.\u003c\/small\u003e\u003c\/p\u003e\n\n  \u003ch2\u003eFrom blood-collection booking to physician assessment\u003c\/h2\u003e\n  \u003col\u003e\n    \u003cli\u003e\u003cstrong\u003eConsultation and booking:\u003c\/strong\u003e Treatment goals, medical history, medications, blood-related considerations, and recent procedures are reviewed first.\u003c\/li\u003e\n    \u003cli\u003e\u003cstrong\u003eBlood collection and aseptic preparation:\u003c\/strong\u003e The sample is sent through the formal preparation process. Collection volume, number of prepared units, and timing follow the selected plan and documents.\u003c\/li\u003e\n    \u003cli\u003e\u003cstrong\u003eTesting and documentation:\u003c\/strong\u003e Relevant preparation or testing information is provided according to the plan and explained by a qualified professional.\u003c\/li\u003e\n    \u003cli\u003e\u003cstrong\u003eRefrigerated storage and cold-chain delivery:\u003c\/strong\u003e Storage conditions, expiry, and use timing follow the product label and formal documents.\u003c\/li\u003e\n    \u003cli\u003e\u003cstrong\u003ePhysician reassessment and planning:\u003c\/strong\u003e Health status, treatment area, product information, and recent procedures are reviewed again before use and follow-up are arranged.\u003c\/li\u003e\n  \u003c\/ol\u003e\n\n  \u003ch2\u003eSkin and scalp concerns require different questions\u003c\/h2\u003e\n  \u003ch3\u003eSkin recovery and condition management\u003c\/h3\u003e\n  \u003cp\u003eFor concerns such as fine lines, dryness, unstable skin condition, or recovery planning, the physician first assesses the cause, current infection or acute inflammation, recent laser or microneedling procedures, and the role PRE may have in the overall plan.\u003c\/p\u003e\n  \u003cp\u003ePRE does not replace the diagnosis of a skin disease, and not every skin concern is treated in the same way. Suitability, combinations, and the observation period are adjusted according to the skin condition and actual response.\u003c\/p\u003e\n  \u003ch3\u003eScalp and hair-loss assessment\u003c\/h3\u003e\n  \u003cp\u003eFor concerns about hair density, roots, or scalp condition, the first step is to assess the pattern and possible cause of hair loss. Genetics, hormones, stress, nutrition, disease, and medication may all contribute.\u003c\/p\u003e\n  \u003cp\u003eAfter the cause is considered, a physician can discuss whether PRE has an appropriate role, whether medication or other treatment is needed, and how progress should be followed. A laboratory value or a single case image cannot predict the same result for everyone.\u003c\/p\u003e\n\n  \u003ch2\u003eWhat should you tell your physician?\u003c\/h2\u003e\n  \u003cp\u003ePlease disclose low platelet counts, platelet dysfunction or other blood disorders, acute or chronic infection, fever, significant medical history, medication that may affect clotting or platelet function, pregnancy, plans for pregnancy, breastfeeding, and recent dental work, surgery, injections, laser treatments, or other procedures.\u003c\/p\u003e\n  \u003cp\u003eDo not stop medication for blood collection or treatment without medical advice. Suitability, timing, and method of use require an individual assessment.\u003c\/p\u003e\n\n  \u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eCan PRE directly replace PRP?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eNot necessarily. Their final form, preparation process, storage requirements, timing, and clinical arrangements differ. The physician considers the treatment goal, medical history, and preferred schedule.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eDoes an autologous source mean there is no risk?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eNo. An autologous source does not make PRE appropriate for everyone and does not replace infection control, blood-collection screening, or review of medical history and medications.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eWhy can’t particle count alone predict the result?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eParticle count is only one part of the product information. Individual condition, goals, method, treatment area, diagnosis, and aftercare also affect the clinical response.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eAre higher PDGF, IGF-1, or Angiogenin values always better?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eNo. The testing method, reference range, product condition, and individual medical context must be considered together. A single high or low value is not an outcome guarantee.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eHow many sessions can follow one blood collection?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eCollection volume, number of prepared units, and scheduling vary by plan, individual condition, and formal preparation documents. The physician explains the arrangement after the preparation result is confirmed.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eCan PRE be combined with laser or microneedling procedures?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eThis can be discussed with a physician. Whether treatments are combined, their order, and the interval depend on the goal, area, skin condition, risks, recent procedures, and expected recovery.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eWhy is PRE not used immediately after blood collection?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003ePRE requires specialized preparation, testing, storage, and delivery. The timeline is confirmed for each case with the preparation facility.\u003c\/p\u003e\u003c\/details\u003e\n  \u003cdetails style=\"padding:14px 0;border-bottom:1px solid #d9e1dc\"\u003e\u003csummary\u003e\u003cstrong\u003eCan I take the prepared product home for storage?\u003c\/strong\u003e\u003c\/summary\u003e\u003cp\u003eStorage, delivery, and use should follow the formal documents and clinic process. Patients should not change the storage conditions independently.\u003c\/p\u003e\u003c\/details\u003e\n\n  \u003ch2\u003eBring your questions to the consultation\u003c\/h2\u003e\n  \u003cp\u003e\u003cstrong\u003eUnderstanding yourself is where thoughtful care begins.\u003c\/strong\u003e\u003c\/p\u003e\n  \u003cp\u003eBring the concerns that matter most to you, your previous procedures, medications, and scheduling needs. Geo Aesthetic Clinic begins by asking whether PRE is appropriate and explains the reasoning behind each step rather than placing every patient into a fixed package.\u003c\/p\u003e\n  \u003cp\u003e\u003ca href=\"\/en\/pages\/location-operating-hours\"\u003eView clinic locations and booking information\u003c\/a\u003e\u003c\/p\u003e\n  \u003cp\u003e\u003csmall\u003eMedical review: \u003ca href=\"\/en\/pages\/medica-team#physician-05\"\u003eDr. Hsieh Hsun-Cheng\u003c\/a\u003e | Reviewed: September 27, 2026 | Updated: September 28, 2026\u003c\/small\u003e\u003c\/p\u003e\n  \u003cp\u003e\u003csmall\u003eThis page provides general educational information and an overview of the assessment process. It does not replace a medical diagnosis. Specific indications, method, number and interval of sessions, risks, contraindications, and expected responses require a physician’s assessment and must follow the relevant medical documents.\u003c\/small\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"己研","offers":[{"title":"Default Title","offer_id":48957918871646,"sku":null,"price":0.0,"currency_code":"TWD","in_stock":true}],"url":"https:\/\/geowncare.com\/en\/products\/pre-platelet-rich-exosome","provider":"肌永Geown","version":"1.0","type":"link"}